FR2173691A1 - - Google Patents

Info

Publication number
FR2173691A1
FR2173691A1 FR7206676A FR7206676A FR2173691A1 FR 2173691 A1 FR2173691 A1 FR 2173691A1 FR 7206676 A FR7206676 A FR 7206676A FR 7206676 A FR7206676 A FR 7206676A FR 2173691 A1 FR2173691 A1 FR 2173691A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7206676A
Other versions
FR2173691B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unicler
Original Assignee
Unicler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE795893D priority Critical patent/BE795893A/fr
Application filed by Unicler filed Critical Unicler
Priority to FR7206676A priority patent/FR2173691B1/fr
Priority to DE2308494A priority patent/DE2308494C3/de
Priority to NL7302571A priority patent/NL7302571A/xx
Priority to GB938173A priority patent/GB1376096A/en
Priority to ES412059A priority patent/ES412059A1/es
Priority to US336242A priority patent/US3910959A/en
Priority to CH281673A priority patent/CH562819A5/xx
Priority to CA164,773A priority patent/CA989410A/en
Publication of FR2173691A1 publication Critical patent/FR2173691A1/fr
Application granted granted Critical
Publication of FR2173691B1 publication Critical patent/FR2173691B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
FR7206676A 1972-02-28 1972-02-28 Expired FR2173691B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BE795893D BE795893A (fr) 1972-02-28 Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique
FR7206676A FR2173691B1 (fr) 1972-02-28 1972-02-28
DE2308494A DE2308494C3 (de) 1972-02-28 1973-02-21 1 -(3,4-Methylendioxyphenyl)-4,4dimethyl-l-penten-3-ol, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
NL7302571A NL7302571A (fr) 1972-02-28 1973-02-23
GB938173A GB1376096A (en) 1972-02-28 1973-02-26 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives
ES412059A ES412059A1 (es) 1972-02-28 1973-02-26 Procedimiento para la preparacion de derivados de 1-(3,4- metilendioxifenil)-4,4-dimetil-1-penteno.
US336242A US3910959A (en) 1972-02-28 1973-02-27 1-(3,4-Methylenedioxy-phenyl)-4,4-dimethyl-pent-1-en-3-ol
CH281673A CH562819A5 (fr) 1972-02-28 1973-02-27
CA164,773A CA989410A (en) 1972-02-28 1973-02-28 1-(3,4-methylenedioxy-phenyl)-4,4-dimethyl-1-pentene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7206676A FR2173691B1 (fr) 1972-02-28 1972-02-28

Publications (2)

Publication Number Publication Date
FR2173691A1 true FR2173691A1 (fr) 1973-10-12
FR2173691B1 FR2173691B1 (fr) 1975-04-25

Family

ID=9094237

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7206676A Expired FR2173691B1 (fr) 1972-02-28 1972-02-28

Country Status (9)

Country Link
US (1) US3910959A (fr)
BE (1) BE795893A (fr)
CA (1) CA989410A (fr)
CH (1) CH562819A5 (fr)
DE (1) DE2308494C3 (fr)
ES (1) ES412059A1 (fr)
FR (1) FR2173691B1 (fr)
GB (1) GB1376096A (fr)
NL (1) NL7302571A (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381765A2 (fr) * 1977-02-23 1978-09-22 Unicler Alcools et cetones a-ethyleniques, leur preparation et leur application comme medicaments
FR2926552A1 (fr) * 2008-01-23 2009-07-24 Biocodex Sa Procede de preparation de particules de stiripentol ayant une granulometrie definie
EP2229943A1 (fr) 2009-03-19 2010-09-22 Biocodex Composé pour son utilisation dans le traitement des neuropathies périphériques
WO2015075155A1 (fr) 2013-11-20 2015-05-28 Biocodex Traitement pharmacologique du trouble obsessionnel compulsif
EP2886116A1 (fr) 2013-12-18 2015-06-24 Biocodex Dérivés du benzodioxol pour leur utilisation dans le traitement du trouble du déficit de l'attention et/ou de l'hyperactivité
WO2017140658A1 (fr) 2016-02-15 2017-08-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de stiripentol et de ses dérivés pour diminuer la concentration d'oxalate urinaire chez un individu
WO2018220068A1 (fr) 2017-05-30 2018-12-06 Biocodex Traitement de maladies associées à une dysrégulation de la voie mtor
FR3121841A1 (fr) 2021-04-20 2022-10-21 Biocodex Traitement des hyperammoniémies

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200464A (en) * 1975-10-16 1980-04-29 Fuji Photo Film Co., Ltd. Silver halide color photographic materials containing a UV filter compound
US4209517A (en) * 1978-07-17 1980-06-24 Unicler α-Ethylenic alcohols and ketones, their preparation, and their use as medicaments
FR2481118A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Application a titre de medicaments de derives substitues de l'acide phenyl-4-oxo-2-butenoique
FR2481270A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Nouveaux derives substitues de l'acide 4-phenyl 4-oxo 2-hydroxy butanoique, procede pour leur preparation et applications comme medicaments
FR2504004A1 (fr) 1981-04-17 1982-10-22 Roussel Uclaf Application a titre de medicaments de derives d'acides phenyl aliphatique carboxyliques
IT1210582B (it) * 1981-10-22 1989-09-14 Roussel Maestretti Spa Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta'farmacologiche e composizioni farmaceutiche che li contengono
IT1171605B (it) * 1981-10-22 1987-06-10 Roussel Maestretti Spa Derivati di acido 4-fenil-4-ossobuten-2-oico farmacologicamente attivi e procedimento per la loro preparazione
FR2515037A1 (fr) * 1981-10-22 1983-04-29 Roussel Uclaf A titre de medicaments, certains derives mono-substitues de l'acide 4-phenyl 4-oxo buten-2-oique, ainsi que les compositions les renfermant
SE454355B (sv) * 1983-01-24 1988-04-25 Roussel Uclaf Akrylsyraderivat innehallande en furyl-, pyranyl-, bensofuranyl-, oxazolyl- eller isoxazolylgrupp, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande nemnda derivat
IT1169783B (it) * 1983-08-25 1987-06-03 Roussel Maestretti Spa Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali
US5095033A (en) * 1991-03-01 1992-03-10 Laboratoires Biocodex Method for treating epilepsy
US10183008B2 (en) 2011-02-09 2019-01-22 University Of South Carolina Treatment of prolonged status epilepticus
CN102391242B (zh) * 2011-12-14 2013-05-08 石家庄博策生物科技有限公司 一种司替戊醇的制备方法
CN102690252B (zh) * 2012-06-18 2014-04-23 湖南大学 一种司替戊醇的制备方法
WO2014087331A2 (fr) * 2012-12-06 2014-06-12 Mahesh Kandula Compositions et méthodes de traitement de l'épilepsie et de maladies neurologiques
US10350192B2 (en) 2015-02-09 2019-07-16 National University Corporation Okayama University Lactate dehydrogenase inhibitor and antiepileptic drug containing the same
HRP20220463T1 (hr) 2016-12-16 2022-05-27 Idorsia Pharmaceuticals Ltd Farmaceutska kombinacija koja sadrži blokator kalcijevih kanala t-tipa

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1583930A (fr) * 1968-06-27 1969-12-05

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1583930A (fr) * 1968-06-27 1969-12-05

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381765A2 (fr) * 1977-02-23 1978-09-22 Unicler Alcools et cetones a-ethyleniques, leur preparation et leur application comme medicaments
FR2926552A1 (fr) * 2008-01-23 2009-07-24 Biocodex Sa Procede de preparation de particules de stiripentol ayant une granulometrie definie
EP2090574A1 (fr) 2008-01-23 2009-08-19 Biocodex Procédé de préparation de particules de stiripentol ayant une granulométrie définie
EP2229943A1 (fr) 2009-03-19 2010-09-22 Biocodex Composé pour son utilisation dans le traitement des neuropathies périphériques
WO2015075155A1 (fr) 2013-11-20 2015-05-28 Biocodex Traitement pharmacologique du trouble obsessionnel compulsif
EP2886116A1 (fr) 2013-12-18 2015-06-24 Biocodex Dérivés du benzodioxol pour leur utilisation dans le traitement du trouble du déficit de l'attention et/ou de l'hyperactivité
WO2015091718A1 (fr) 2013-12-18 2015-06-25 Biocodex Dérivés de benzodioxol pour une utilisation dans le traitement de déficit de l'attention et/ou de l'hyperactivité
WO2017140658A1 (fr) 2016-02-15 2017-08-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de stiripentol et de ses dérivés pour diminuer la concentration d'oxalate urinaire chez un individu
WO2018220068A1 (fr) 2017-05-30 2018-12-06 Biocodex Traitement de maladies associées à une dysrégulation de la voie mtor
FR3121841A1 (fr) 2021-04-20 2022-10-21 Biocodex Traitement des hyperammoniémies
WO2022223636A1 (fr) 2021-04-20 2022-10-27 Biocodex Traitement des hyperammoniémies

Also Published As

Publication number Publication date
GB1376096A (en) 1974-12-04
ES412059A1 (es) 1976-01-01
US3910959A (en) 1975-10-07
NL7302571A (fr) 1973-08-30
FR2173691B1 (fr) 1975-04-25
DE2308494B2 (de) 1977-08-18
BE795893A (fr) 1973-06-18
CH562819A5 (fr) 1975-06-13
CA989410A (en) 1976-05-18
DE2308494C3 (de) 1978-04-20
DE2308494A1 (de) 1973-09-06

Similar Documents

Publication Publication Date Title
FR2173691B1 (fr)
AU4040772A (fr)
CH562161A5 (fr)
BG17990A1 (fr)
BG18050A1 (fr)
BG18502A1 (fr)
BG19971A1 (fr)
BG21266A1 (fr)
BG22750A1 (fr)
BG22845A3 (fr)
CH1372372A4 (fr)
CH1570573A4 (fr)
CH551286A (fr)
CH553445A (fr)
CH559392A5 (fr)
CH559458A5 (fr)
CH559570A5 (fr)
CH560134A5 (fr)
CH560355A5 (fr)
CH560717A5 (fr)
CH561632A5 (fr)
CH561861A5 (fr)
CH562136A5 (fr)
CH564104A5 (fr)
CH565149A5 (fr)

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
TP Transmission of property